Salud ósea en pacientes sometidos a trasplante de precursores hematopoyéticos: un nuevo problema a considerar

Background: Patients undergoing hematopoietic cell transplantation (HCT) are at increased risk of developing osteoporosis. Aim: To determine the frequency and severity of Vitamin D deficiency, secondary hyperparathyroidism and low bone mass in patients undergoing HCT. Patients and Methods: Analysis...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Florenzano,Pablo, Ernst,Daniel, Lustig,Nicole, Rojas,Patricio, Ramírez,Pablo, Campusano,Claudia
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2016
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000900004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872016000900004
record_format dspace
spelling oai:scielo:S0034-988720160009000042016-12-23Salud ósea en pacientes sometidos a trasplante de precursores hematopoyéticos: un nuevo problema a considerarFlorenzano,PabloErnst,DanielLustig,NicoleRojas,PatricioRamírez,PabloCampusano,Claudia Hematopoietic Stem Cell Transplantation Hyperparathyroidism Secondary Osteoporosis Vitamin D Background: Patients undergoing hematopoietic cell transplantation (HCT) are at increased risk of developing osteoporosis. Aim: To determine the frequency and severity of Vitamin D deficiency, secondary hyperparathyroidism and low bone mass in patients undergoing HCT. Patients and Methods: Analysis of the database of patients undergoing HCT in our institution in the 2010-2015 period. We searched for patients with measurements of 25-OH vitamin D (25OHD), parathyroid hormone (PTH) and bone densitometry by double beam X ray absorptiometry (DXA) prior and up to one year after HCT. Results: Ninety patients were included, 53 were evaluated prior to HCT and 37 after HCT. They represent 73% of all patients undergoing HCT in the period. Median 25OHD was 12 ng/ml (range 4-41.4). Ninety seven percent of patients had levels considered insufficient and 85% compatible with deficiency. Median PTH was 60.5 pg/ml (range 21-186). Forty five percent of patients had secondary hyperparathyroidism. DXA was performed in 65 patients (prior to HCT in 54 and after HCT in 11). Of these, 11% had had a low bone mineral density. Conclusions: Patients undergoing HCT have a high risk of vitamin D deficiency, secondary hyperparathyroidism and low bone mineral density.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.144 n.9 20162016-09-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000900004es10.4067/S0034-98872016000900004
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Hematopoietic Stem Cell Transplantation
Hyperparathyroidism Secondary
Osteoporosis
Vitamin D
spellingShingle Hematopoietic Stem Cell Transplantation
Hyperparathyroidism Secondary
Osteoporosis
Vitamin D
Florenzano,Pablo
Ernst,Daniel
Lustig,Nicole
Rojas,Patricio
Ramírez,Pablo
Campusano,Claudia
Salud ósea en pacientes sometidos a trasplante de precursores hematopoyéticos: un nuevo problema a considerar
description Background: Patients undergoing hematopoietic cell transplantation (HCT) are at increased risk of developing osteoporosis. Aim: To determine the frequency and severity of Vitamin D deficiency, secondary hyperparathyroidism and low bone mass in patients undergoing HCT. Patients and Methods: Analysis of the database of patients undergoing HCT in our institution in the 2010-2015 period. We searched for patients with measurements of 25-OH vitamin D (25OHD), parathyroid hormone (PTH) and bone densitometry by double beam X ray absorptiometry (DXA) prior and up to one year after HCT. Results: Ninety patients were included, 53 were evaluated prior to HCT and 37 after HCT. They represent 73% of all patients undergoing HCT in the period. Median 25OHD was 12 ng/ml (range 4-41.4). Ninety seven percent of patients had levels considered insufficient and 85% compatible with deficiency. Median PTH was 60.5 pg/ml (range 21-186). Forty five percent of patients had secondary hyperparathyroidism. DXA was performed in 65 patients (prior to HCT in 54 and after HCT in 11). Of these, 11% had had a low bone mineral density. Conclusions: Patients undergoing HCT have a high risk of vitamin D deficiency, secondary hyperparathyroidism and low bone mineral density.
author Florenzano,Pablo
Ernst,Daniel
Lustig,Nicole
Rojas,Patricio
Ramírez,Pablo
Campusano,Claudia
author_facet Florenzano,Pablo
Ernst,Daniel
Lustig,Nicole
Rojas,Patricio
Ramírez,Pablo
Campusano,Claudia
author_sort Florenzano,Pablo
title Salud ósea en pacientes sometidos a trasplante de precursores hematopoyéticos: un nuevo problema a considerar
title_short Salud ósea en pacientes sometidos a trasplante de precursores hematopoyéticos: un nuevo problema a considerar
title_full Salud ósea en pacientes sometidos a trasplante de precursores hematopoyéticos: un nuevo problema a considerar
title_fullStr Salud ósea en pacientes sometidos a trasplante de precursores hematopoyéticos: un nuevo problema a considerar
title_full_unstemmed Salud ósea en pacientes sometidos a trasplante de precursores hematopoyéticos: un nuevo problema a considerar
title_sort salud ósea en pacientes sometidos a trasplante de precursores hematopoyéticos: un nuevo problema a considerar
publisher Sociedad Médica de Santiago
publishDate 2016
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000900004
work_keys_str_mv AT florenzanopablo saludoseaenpacientessometidosatrasplantedeprecursoreshematopoyeticosunnuevoproblemaaconsiderar
AT ernstdaniel saludoseaenpacientessometidosatrasplantedeprecursoreshematopoyeticosunnuevoproblemaaconsiderar
AT lustignicole saludoseaenpacientessometidosatrasplantedeprecursoreshematopoyeticosunnuevoproblemaaconsiderar
AT rojaspatricio saludoseaenpacientessometidosatrasplantedeprecursoreshematopoyeticosunnuevoproblemaaconsiderar
AT ramirezpablo saludoseaenpacientessometidosatrasplantedeprecursoreshematopoyeticosunnuevoproblemaaconsiderar
AT campusanoclaudia saludoseaenpacientessometidosatrasplantedeprecursoreshematopoyeticosunnuevoproblemaaconsiderar
_version_ 1718436902719193088